Million Equity Investment from AMD Strengthens Absci’s Leadership in AI Drug Discovery and Further Expands Biopharma Adoption of AMD Instinct Accelerators and ROCm SoftwareVANCOUVER, Wash., Jan. 08, ...
Orbis Medicines, a leader in oral macrocycle drug discovery, today announces the close of a EUR 90 million Series A funding round, bringing the total amount raised by the company to EUR 116 million.
Additionally, investors should not forget that J.P. Morgan's exposure to macroeconomic cycles leaves it vulnerable to credit quality deterioration and reduced loan demand if economic growth falters.
Morgan Stanley stays bullish on Apple going into 2025, citing accelerated iPhone replacement cycles, double-digit services ... Among active stocks. J.P. Morgan upgraded Okta (OKTA) to Overweight ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...